These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12065708)

  • 1. A single dose of monoclonal anti-phencyclidine IgG offers long-term reductions in phencyclidine behavioral effects in rats.
    Hardin JS; Wessinger WD; Wenger GR; Proksch JW; Laurenzana EM; Owens SM
    J Pharmacol Exp Ther; 2002 Jul; 302(1):119-26. PubMed ID: 12065708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-phencyclidine monoclonal antibodies provide long-term reductions in brain phencyclidine concentrations during chronic phencyclidine administration in rats.
    Proksch JW; Gentry WB; Owens SM
    J Pharmacol Exp Ther; 2000 Mar; 292(3):831-7. PubMed ID: 10688594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-phencyclidine monoclonal antibody binding capacity is not the only determinant of effectiveness, disproving the concept that antibody capacity is easily surmounted.
    Pitas G; Laurenzana EM; Williams DK; Owens SM; Gentry WB
    Drug Metab Dispos; 2006 Jun; 34(6):906-12. PubMed ID: 16507651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of adverse effects of excessive phencyclidine exposure in rats with a minimal dose of monoclonal antibody.
    Laurenzana EM; Gunnell MG; Gentry WB; Owens SM
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1092-8. PubMed ID: 12829731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats.
    Valentine JL; Mayersohn M; Wessinger WD; Arnold LW; Owens SM
    J Pharmacol Exp Ther; 1996 Aug; 278(2):709-16. PubMed ID: 8768722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered adult locomotor activity in rats from phencyclidine treatment on postnatal days 7, 9 and 11, but not repeated ketamine treatment on postnatal day 7.
    Boctor SY; Ferguson SA
    Neurotoxicology; 2010 Jan; 31(1):42-54. PubMed ID: 19853622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the mGlu2/3 receptor agonist LY379268 on motor activity in phencyclidine-sensitized rats.
    Clark M; Johnson BG; Wright RA; Monn JA; Schoepp DD
    Pharmacol Biochem Behav; 2002 Sep; 73(2):339-46. PubMed ID: 12117588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of anti-phencyclidine and anti-(+)-methamphetamine monoclonal antibodies alone and in combination on the discrimination of phencyclidine and (+)-methamphetamine by pigeons.
    Daniels JR; Wessinger WD; Hardwick WC; Li M; Gunnell MG; Hall CJ; Owens SM; McMillan DE
    Psychopharmacology (Berl); 2006 Mar; 185(1):36-44. PubMed ID: 16479372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics of a monoclonal antiphencyclidine Fab with broad selectivity for phencyclidine-like drugs.
    Hardin JS; Wessinger WD; Proksch JW; Owens SM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1113-22. PubMed ID: 9618414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical anti-schizophrenic drugs prevent changes in cortical N-methyl-D-aspartate receptors and behavior following sub-chronic phencyclidine administration in developing rat pups.
    Anastasio NC; Johnson KM
    Pharmacol Biochem Behav; 2008 Oct; 90(4):569-77. PubMed ID: 18544461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic phencyclidine induces behavioral sensitization and apoptotic cell death in the olfactory and piriform cortex.
    Johnson KM; Phillips M; Wang C; Kevetter GA
    J Neurosci Res; 1998 Jun; 52(6):709-22. PubMed ID: 9669320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphencyclidine monoclonal antibody therapy significantly changes phencyclidine concentrations in brain and other tissues in rats.
    Valentine JL; Owens SM
    J Pharmacol Exp Ther; 1996 Aug; 278(2):717-24. PubMed ID: 8768723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of MS-153 on the development of behavioral sensitization to stereotypy-inducing effect of phencyclidine.
    Abekawa T; Honda M; Ito K; Inoue T; Koyama T
    Brain Res; 2002 Feb; 926(1-2):176-80. PubMed ID: 11814421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic anti-phencyclidine monoclonal antibody therapy decreases phencyclidine-induced in utero fetal mortality in pregnant rats.
    Hubbard JJ; Laurenzana EM; Williams DK; Gentry WB; Owens SM
    Int Immunopharmacol; 2011 Dec; 11(12):2181-7. PubMed ID: 22001428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of repeated haloperidol administration on phencyclidine discrimination in rats.
    Wiley JL
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Jul; 19(4):699-711. PubMed ID: 8588067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phencyclidine supersensitivity in rats with neonatal dopamine loss.
    Moy SS; Breese GR
    Psychopharmacology (Berl); 2002 May; 161(3):255-62. PubMed ID: 12021828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic mechanisms for obtaining high renal coelimination of phencyclidine and a monoclonal antiphencyclidine antigen-binding fragment of immunoglobulin G in the rat.
    Proksch JW; Gentry WB; Owens SM
    J Pharmacol Exp Ther; 1998 Nov; 287(2):616-24. PubMed ID: 9808688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subchronic phencyclidine in rats: alterations in locomotor activity, maze performance, and GABA(A) receptor binding.
    Beninger RJ; Beuk J; Banasikowski TJ; van Adel M; Boivin GA; Reynolds JN
    Behav Pharmacol; 2010 Feb; 21(1):1-10. PubMed ID: 19949321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subchronic treatment with phencyclidine in adolescence leads to impaired exploratory behavior in adult rats without altering social interaction or N-methyl-D-aspartate receptor binding levels.
    Metaxas A; Willems R; Kooijman EJ; Renjaän VA; Klein PJ; Windhorst AD; Donck LV; Leysen JE; Berckel BN
    J Neurosci Res; 2014 Nov; 92(11):1599-607. PubMed ID: 24953757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
    Cartmell J; Monn JA; Schoepp DD
    J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.